# Goodyear Tire & Rubber Co: financial statements, quarterly

GT · Nasdaq · CIK 42582 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gt.md) · [Financials](/companies/gt/financials.md) · [Filings](/companies/gt/filings.md) · [Insiders](/companies/gt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,142](/filings/0000950170-24-121152.md) | [5,116 d](/filings/0001628280-26-006708.md) | [4,537](/filings/0000950170-25-066579.md) | [4,570](/filings/0001628280-25-039165.md) | [4,824](/filings/0001628280-25-048584.md) | [4,947 d](/filings/0001628280-26-006708.md) | [4,253](/filings/0001628280-26-031866.md) | [4,465](/filings/0001628280-26-054032.md) | [4,645](/filings/0001628280-25-048584.md) | [4,917 d](/filings/0001628280-26-006708.md) | [3,881](/filings/0001628280-26-031866.md) | [4,250](/filings/0001628280-26-054032.md) |
| Cost of revenue | $m | [4,171](/filings/0000950170-24-121152.md) | [4,095 d](/filings/0001628280-26-006708.md) | [3,722](/filings/0001628280-25-039165.md) | [3,627](/filings/0001628280-25-039165.md) | [3,882](/filings/0001628280-25-048584.md) | [3,961 d](/filings/0001628280-26-006708.md) | [3,513](/filings/0001628280-26-031866.md) | [3,705](/filings/0001628280-26-054032.md) | [3,801](/filings/0001628280-25-048584.md) | [3,890 d](/filings/0001628280-26-006708.md) | [3,188](/filings/0001628280-26-031866.md) | [3,569](/filings/0001628280-26-054032.md) |
| Selling, general and administrative | $m | [673](/filings/0000950170-24-121152.md) | [769 d](/filings/0001628280-26-006708.md) | [696](/filings/0000950170-25-066579.md) | [731](/filings/0001628280-25-039165.md) | [663](/filings/0001628280-25-048584.md) | [692 d](/filings/0001628280-26-006708.md) | [650](/filings/0001628280-26-031866.md) | [692](/filings/0001628280-26-054032.md) | [676](/filings/0001628280-25-048584.md) | [701 d](/filings/0001628280-26-006708.md) | [668](/filings/0001628280-26-031866.md) | [703](/filings/0001628280-26-054032.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [138](/filings/0000950170-24-121152.md) | [129 d](/filings/0000950170-25-020763.md) | [126](/filings/0000950170-25-066579.md) | [130](/filings/0000950170-24-089017.md) | [135](/filings/0000950170-24-121152.md) | [131 d](/filings/0000950170-25-020763.md) | [115](/filings/0000950170-25-066579.md) | [112](/filings/0001628280-26-054032.md) | [114](/filings/0001628280-25-048584.md) | [104 d](/filings/0001628280-26-006708.md) | [95.0](/filings/0001628280-26-031866.md) | [105](/filings/0001628280-26-054032.md) |
| Income tax | $m | [25.0](/filings/0000950170-24-121152.md) | [(12.0) d](/filings/0001628280-26-006708.md) | [6.0](/filings/0000950170-25-066579.md) | [60.0](/filings/0001628280-25-039165.md) | [9.0](/filings/0001628280-25-048584.md) | [20.0 d](/filings/0001628280-26-006708.md) | [13.0](/filings/0001628280-26-031866.md) | [24.0](/filings/0001628280-26-054032.md) | [1,464](/filings/0001628280-25-048584.md) | [66.0 d](/filings/0001628280-26-006708.md) | [66.0](/filings/0001628280-26-031866.md) | [46.0](/filings/0001628280-26-054032.md) |
| Net income | $m | [(89.0)](/filings/0000950170-24-121152.md) | [(331) d](/filings/0001628280-26-006708.md) | [(69.0)](/filings/0001628280-25-039165.md) | [79.0](/filings/0001628280-25-039165.md) | [(37.0)](/filings/0001628280-25-048584.md) | [73.0 d](/filings/0001628280-26-006708.md) | [115](/filings/0001628280-26-031866.md) | [254](/filings/0001628280-26-054032.md) | [(2,195)](/filings/0001628280-25-048584.md) | [105 d](/filings/0001628280-26-006708.md) | [(249)](/filings/0001628280-26-031866.md) | [(204)](/filings/0001628280-26-054032.md) |
| Diluted EPS | $ per share | [(0.31)](/filings/0000950170-24-121152.md) | not reported | [(0.24)](/filings/0001628280-25-039165.md) | [0.28](/filings/0001628280-25-039165.md) | [(0.13)](/filings/0001628280-25-048584.md) | not reported | [0.40](/filings/0001628280-26-031866.md) | [0.87](/filings/0001628280-26-054032.md) | [(7.62)](/filings/0001628280-25-048584.md) | not reported | [(0.86)](/filings/0001628280-26-031866.md) | [(0.71)](/filings/0001628280-26-054032.md) |
| Basic EPS | $ per share | [(0.31)](/filings/0000950170-24-121152.md) | not reported | [(0.24)](/filings/0001628280-25-039165.md) | [0.28](/filings/0001628280-25-039165.md) | [(0.13)](/filings/0001628280-25-048584.md) | not reported | [0.40](/filings/0001628280-26-031866.md) | [0.88](/filings/0001628280-26-054032.md) | [(7.62)](/filings/0001628280-25-048584.md) | not reported | [(0.86)](/filings/0001628280-26-031866.md) | [(0.71)](/filings/0001628280-26-054032.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0000950170-24-121152.md) | [0.9](/filings/0001628280-26-006708.md) | [0.9](/filings/0000950170-25-066579.md) | [0.8](/filings/0001628280-25-039165.md) | [0.9](/filings/0001628280-25-048584.md) | [0.8](/filings/0001628280-26-006708.md) | [0.9](/filings/0001628280-26-031866.md) | [0.8](/filings/0001628280-26-054032.md) | [0.8](/filings/0001628280-25-048584.md) | [0.8](/filings/0001628280-26-054032.md) | [0.7](/filings/0001628280-26-031866.md) | [0.9](/filings/0001628280-26-054032.md) |
| Current assets | $bn | [8.7](/filings/0000950170-23-059862.md) | [7.6](/filings/0001628280-25-039165.md) | [8.1](/filings/0000950170-24-054023.md) | [8.2](/filings/0000950170-24-089017.md) | [8.9](/filings/0000950170-24-121152.md) | [7.6](/filings/0001628280-26-006708.md) | [8.4](/filings/0000950170-25-066579.md) | [8.9](/filings/0001628280-25-039165.md) | [9.0](/filings/0001628280-25-048584.md) | [7.2](/filings/0001628280-26-054032.md) | [7.6](/filings/0001628280-26-031866.md) | [7.9](/filings/0001628280-26-054032.md) |
| Total assets | $bn | [22.5](/filings/0000950170-23-059862.md) | [21.6](/filings/0001628280-25-039165.md) | [22.0](/filings/0000950170-24-054023.md) | [22.0](/filings/0000950170-24-089017.md) | [22.5](/filings/0000950170-24-121152.md) | [20.9](/filings/0001628280-26-006708.md) | [21.7](/filings/0000950170-25-066579.md) | [22.3](/filings/0001628280-25-039165.md) | [20.2](/filings/0001628280-25-048584.md) | [18.2](/filings/0001628280-26-054032.md) | [18.5](/filings/0001628280-26-031866.md) | [18.7](/filings/0001628280-26-054032.md) |
| Current liabilities | $bn | [6.7](/filings/0000950170-23-059862.md) | [7.2](/filings/0001628280-25-039165.md) | [7.0](/filings/0000950170-24-054023.md) | [7.7](/filings/0000950170-24-089017.md) | [7.8](/filings/0000950170-24-121152.md) | [7.4](/filings/0001628280-26-006708.md) | [6.9](/filings/0000950170-25-066579.md) | [7.7](/filings/0001628280-25-039165.md) | [7.1](/filings/0001628280-25-048584.md) | [6.8](/filings/0001628280-26-054032.md) | [7.4](/filings/0001628280-26-031866.md) | [7.3](/filings/0001628280-26-054032.md) |
| Total liabilities | $bn | [17.3](/filings/0000950170-23-059862.md) | [16.8](/filings/0001628280-25-039165.md) | [17.2](/filings/0000950170-24-054023.md) | [17.2](/filings/0000950170-24-089017.md) | [17.6](/filings/0000950170-24-121152.md) | [16.1](/filings/0001628280-26-006708.md) | [16.6](/filings/0000950170-25-066579.md) | [17.0](/filings/0001628280-25-039165.md) | [17.0](/filings/0001628280-25-048584.md) | [14.8](/filings/0001628280-26-054032.md) | [15.3](/filings/0001628280-26-031866.md) | [15.6](/filings/0001628280-26-054032.md) |
| Long-term debt | $bn | [8.1](/filings/0000950170-23-059862.md) | [7.0](/filings/0000950170-25-020763.md) | [7.6](/filings/0000950170-24-054023.md) | [7.8](/filings/0000950170-24-089017.md) | [8.2](/filings/0000950170-24-121152.md) | [7.0](/filings/0001628280-26-006708.md) | [7.3](/filings/0000950170-25-066579.md) | [7.1](/filings/0001628280-25-039165.md) | [7.2](/filings/0001628280-25-048584.md) | [5.4](/filings/0001628280-26-054032.md) | [6.2](/filings/0001628280-26-031866.md) | [6.6](/filings/0001628280-26-054032.md) |
| Current portion of debt | $bn | [0.6](/filings/0000950170-23-059862.md) | [0.8](/filings/0000950170-25-020763.md) | [0.8](/filings/0000950170-24-054023.md) | [1.6](/filings/0000950170-24-089017.md) | [1.6](/filings/0000950170-24-121152.md) | [1.4](/filings/0001628280-26-006708.md) | [0.7](/filings/0000950170-25-066579.md) | [1.3](/filings/0001628280-25-039165.md) | [0.8](/filings/0001628280-25-048584.md) | [0.9](/filings/0001628280-26-054032.md) | [1.7](/filings/0001628280-26-031866.md) | [1.4](/filings/0001628280-26-054032.md) |
| Short-term borrowings | $bn | [0.3](/filings/0000950170-23-059862.md) | [0.3](/filings/0000950170-25-020763.md) | [0.4](/filings/0000950170-24-054023.md) | [0.5](/filings/0000950170-24-089017.md) | [0.6](/filings/0000950170-24-121152.md) | [0.6](/filings/0001628280-26-006708.md) | [0.4](/filings/0000950170-25-066579.md) | [0.5](/filings/0001628280-25-039165.md) | [0.6](/filings/0001628280-25-048584.md) | [0.5](/filings/0001628280-26-054032.md) | [0.5](/filings/0001628280-26-031866.md) | [0.4](/filings/0001628280-26-054032.md) |
| Shareholders' equity | $bn | [5.0](/filings/0000950170-23-059862.md) | [4.6](/filings/0001628280-25-039165.md) | [4.6](/filings/0000950170-24-054023.md) | [4.7](/filings/0000950170-24-089017.md) | [4.7](/filings/0000950170-24-121152.md) | [4.7](/filings/0001628280-26-006708.md) | [4.9](/filings/0000950170-25-066579.md) | [5.1](/filings/0001628280-25-039165.md) | [3.0](/filings/0001628280-25-048584.md) | [3.2](/filings/0001628280-26-054032.md) | [3.0](/filings/0001628280-26-031866.md) | [2.8](/filings/0001628280-26-054032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [230 d](/filings/0000950170-24-121152.md) | [1,236 d](/filings/0001628280-26-006708.md) | [(451)](/filings/0000950170-25-066579.md) | [(67.0) d](/filings/0001628280-25-039165.md) | [(73.0) d](/filings/0001628280-25-048584.md) | [1,289 d](/filings/0001628280-26-006708.md) | [(538)](/filings/0001628280-26-031866.md) | [(180) d](/filings/0001628280-26-054032.md) | [2.0 d](/filings/0001628280-25-048584.md) | [1,512 d](/filings/0001628280-26-006708.md) | [(718)](/filings/0001628280-26-031866.md) | [98.0 d](/filings/0001628280-26-054032.md) |
| Capital expenditure | $m | [271 d](/filings/0000950170-24-121152.md) | [243 d](/filings/0001628280-26-006708.md) | [318](/filings/0000950170-25-066579.md) | [316 d](/filings/0001628280-25-039165.md) | [278 d](/filings/0001628280-25-048584.md) | [276 d](/filings/0001628280-26-006708.md) | [259](/filings/0001628280-26-031866.md) | [207 d](/filings/0001628280-26-054032.md) | [183 d](/filings/0001628280-25-048584.md) | [177 d](/filings/0001628280-26-006708.md) | [175](/filings/0001628280-26-031866.md) | [167 d](/filings/0001628280-26-054032.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [286](/filings/0000950170-23-059862.md) | [285](/filings/0000950170-24-054023.md) | [285](/filings/0000950170-24-089017.md) | [285](/filings/0000950170-24-121152.md) | [286](/filings/0000950170-25-066579.md) | [288](/filings/0001628280-25-039165.md) | [287](/filings/0001628280-25-048584.md) | [289](/filings/0001628280-26-031866.md) | [290](/filings/0001628280-26-054032.md) | [288](/filings/0001628280-25-048584.md) | [288](/filings/0001628280-26-031866.md) | [289](/filings/0001628280-26-054032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 287,898,737 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.